Ultralife (ULBI)
(Delayed Data from NSDQ)
$10.46 USD
-0.29 (-2.70%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $10.43 -0.03 (-0.29%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Ultralife Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 159 | 132 | 98 | 108 | 107 |
Cost Of Goods | 119 | 102 | 74 | 79 | 76 |
Gross Profit | 39 | 29 | 25 | 29 | 31 |
Selling & Adminstrative & Depr. & Amort Expenses | 30 | 29 | 25 | 23 | 24 |
Income After Depreciation & Amortization | 9 | 0 | 0 | 6 | 7 |
Non-Operating Income | 2 | 0 | 0 | 2 | 0 |
Interest Expense | 2 | 1 | 0 | 0 | 1 |
Pretax Income | 9 | 0 | 0 | 7 | 7 |
Income Taxes | 2 | 0 | 0 | 2 | 1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 7 | 0 | 0 | 5 | 5 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 7 | 0 | 0 | 5 | 5 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 13 | 5 | 4 | 9 | 10 |
Depreciation & Amortization (Cash Flow) | 4 | 5 | 4 | 3 | 3 |
Income After Depreciation & Amortization | 9 | 0 | 0 | 6 | 7 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 16.23 | 16.13 | 16.04 | 16.10 | 16.18 |
Diluted EPS Before Non-Recurring Items | 0.52 | 0.06 | -0.02 | 0.42 | 0.40 |
Diluted Net EPS (GAAP) | 0.44 | -0.01 | -0.01 | 0.33 | 0.32 |
Fiscal Year end for Ultralife Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 42.98 | 41.93 | 44.55 | 39.49 | 42.69 |
Cost Of Goods | 31.42 | 30.46 | 33.15 | 29.71 | 32.10 |
Gross Profit | 11.56 | 11.47 | 11.40 | 9.77 | 10.59 |
SG&A, R&D, and Dept/Amort Expenses | 7.65 | 7.41 | 7.75 | 7.64 | 6.93 |
Income After SG&A, R&D, and Dept/Amort Expenses | 3.91 | 4.06 | 3.65 | 2.13 | 3.66 |
Non-Operating Income | 0.35 | 0.06 | 0.03 | 0.20 | 1.50 |
Interest Expense | 0.42 | 0.52 | 0.57 | 0.59 | 0.44 |
Pretax Income | 3.85 | 3.61 | 3.11 | 1.75 | 4.72 |
Income Taxes | 0.85 | 0.70 | 0.26 | 0.45 | 1.38 |
Minority Interest | 0.02 | 0.01 | -0.02 | -0.03 | 0.01 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 2.99 | 2.90 | 2.85 | 1.30 | 3.35 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 2.97 | 2.89 | 2.87 | 1.33 | 3.34 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 16.83 | 16.52 | 16.48 | 16.30 | 16.14 |
Diluted EPS Before Non-Recurring Items | 0.22 | 0.21 | 0.18 | 0.10 | 0.29 |
Diluted Net EPS (GAAP) | 0.18 | 0.18 | 0.17 | 0.08 | 0.21 |